Article info
PDFPostScript
Letter
Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study
- Correspondence to Professor Xiaolong Qi, CHESS Center, Institute of Portal Hypertension, Lanzhou University First Affiliated Hospital, Lanzhou 730000, China; qixiaolong{at}vip.163.com; Dr Bin Xiong, Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; herr_xiong{at}126.com
Citation
Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study
Publication history
- Received May 1, 2020
- Revised May 11, 2020
- Accepted May 12, 2020
- First published May 20, 2020.
Online issue publication
January 07, 2021
Article Versions
- Previous version (20 May 2020).
- Previous version (3 June 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.